Úplné zobrazení záznamu

Toto je statický export z katalogu ze dne 19.12.2020. Zobrazit aktuální podobu v katalogu.

Bibliografická citace

.
0 (hodnocen0 x )
BK
4th edition
Lyon : International Agency for Research on Cancer, 2018
470 stran : barevné ilustrace ; 27 cm

objednat
ISBN 978-92-832-2440-2 (brožováno)
World Health Organization classification of tumours
Nad názvem: WHO, OMS, International Agency for Research on Cancer (IARC)
Obsahuje bibliografii na stranách 415-461 a rejstřík
001484728
Contents // -? Classification of skin tumours 10 // classification of skin tumours 14 // Carcinoma of skin 14 // Skin carcinoma of the head and neck 15 // Carcinoma of skin of the eyelid 16 // Ma gnant melanoma of skin 17 // Verkel cell carcinoma of skin 19 // Soft tissue sarcoma of skin 20 //  rnary cutaneous lymphomas 21 // ’ Keratinocytic/epidermal tumours 23 //  traduction 24 // Carcinomas 24 // Carcinoma precursors and benign simulants 25 // Carcinomas // Basal cell carcinoma 26 // Nodular basal cell carcinoma 27 // Superficial basal cell carcinoma 28 // Micronodular basal cell carcinoma 29 // Infiltrating basal cell carcinoma 30 // Sclerosing/morphoeic basal cell carcinoma 30 // Basosquamous carcinoma 31 // Pigmented basal cell carcinoma 32 // Basal cell carcinoma with sarcomatoid differentiation 32 Basal cell carcinoma with adnexal differentiation 33 // Fibroepithelial basal cell carcinoma 34 // Squamous cell carcinoma 35 // Squamous cell carcinoma 35 // Keratoacanthoma 36 // Acantholytic squamous cell carcinoma 38 // Spindle cell squamous cell carcinoma 40 // Verrucous squamous cell carcinoma 41 // Adenosquamous carcinoma 42 // Clear cell squamous cell carcinoma 43 // Other (uncommon) variants 44 // Squamous cell carcinoma in situ (Bowen disease) 46 // Merkel cell carcinoma // Carcinoma precursors and benign simulants // Premalignant keratoses 51 // Actinic keratosis 31 // Arsenical keratosis 52 // PUVA keratosis 53 // Verrucae 34 // Verruca vulgaris 34 // Verruca plantaris
55 // Verruca plana 56 // Benign acanthomas/keratoses 57 // Seborrhoeic keratosis 57 // Solar lentigo 59 // Lichen planus-like keratosis 60 // Clear cell acanthoma 60 // Large cell acanthoma 61 // Warty dyskeratoma 62 // Other benign keratoses 63 // 2 // Melanocytic tumours // Introduction // Melanocytic tumour classification and the // pathway concept of melanoma pathogenesis Genomic landscape of melanoma Melanocytic tumours in intermittently sun-exposed skin Low-CSD melanoma (superficial spreading melanoma) Simple lentigo and lentiginous melanocytic naevus Junctional, compound, and dermal naevi Dysplastic naevus Naevus spilus // Special-site naevi (of the breast, axilla, scalp, and ear) Halo naevus Meyerson naevus Recurrent naevus // Deep penetrating naevus and melanocytoma Pigmented epithelioid melanocytoma Combined naevus, including combined B/4P7-inactivated naevus/ melanocytoma // Melanocytic tumours in chronically sun-exposed skin Lentigo maligna melanoma Desmoplastic melanoma Spitz tumours // Malignant Spitz tumour (Spitz melanoma) // Spitz naevus // Pigmented spindle cell naevus (Reed naevus) Melanocytic tumours in acral skin Acral melanoma Acral naevus // Genital and mucosal melanocytic tumours Mucosal melanomas (genital, oral, sinonasal) // Genital naevus // Melanocytic tumours arising in blue naevus Melanoma arising in blue naevus Blue naevus and cellular blue naevus Mongolian spot // Naevus of Ito and naevus of Ota Melanocytic tumours arising in congenital naevi Melanoma
arising in giant congenital naevus Congenital melanocytic naevus Proliferative nodules in congenital melanocytic naevus Ocular melanocytic tumours Uveal melanoma Conjunctival melanoma // Conjunctival melanocytic intraepithelial neoplasia/ primary acquired melanosis Conjunctival naevus // Nodular, naevoid, and metastatic melanomas Nodular melanoma Naevoid melanoma Metastatic melanoma // 65 // 66 // 66 // 72 // 76 // 76 // 78 // 80 // 82 // 87 // 89 // 91 // 93 // 94 // 95 97 // 99 // 102 // 102 // 105 // 108 // 108 // 111 // 114 // 116 // 116 // 119 // 121 // 121 // 123 // 124 124 126 // 130 // 131 // 132 132 134 // 136 // 137 137 139 // 141 // 143 // 145 // 145 // 147 // 150 // 3 Appendageal tumours 153 // Introduction 154 // Malignant tumours with apocrine and eccrine differentiation 155 Adnexal adenocarcinoma not otherwise specified 155 // Microcystic adnexal carcinoma 157 // Porocarcinoma 159 // Malignant neoplasms arising from spiradenoma, // cylindroma, or spiradenocylindroma 161 // Malignant mixed tumour 163 // Hidradenocarcinoma 164 // Mucinous carcinoma 166 // Endocrine mucin-producing sweat gland carcinoma 168 // Digital papillary adenocarcinoma 170 // Adenoid cystic carcinoma 172 // Apocrine carcinoma 174 // Squamoid eccrine ductal carcinoma 176 // Syringocystadenocarcinoma papilliferum 177 // Secretory carcinoma 179 // Cribriform carcinoma 180 // Signet-ring cell/histiocytoid carcinoma 182 // Benign tumours with apocrine and eccrine differentiation 183 Hidrocystoma/cystadenoma
183 // Syringoma 184 // Poroma 185 // Syringofibroadenoma 186 // Hidradenoma 187 // Spiradenoma 189 // Cylindroma 190 // Tubular adenoma 191 // Syringocystadenoma papilliferum 192 // Mixed tumour 193 // Myoepithelioma 194 // Malignant tumours with follicular differentiation 195 // Pilomatrical carcinoma 195 // Proliferating trichilemmal tumour 196 // Trichoblastic carcinoma/carcinosarcoma 197 // Trichilemmal carcinoma 199 // Benign tumours with follicular differentiation 201 // Trichoblastoma 201 // Pilomatricoma 203 // Trichilemmoma 204 // Trichofolliculoma 206 // Pilar sheath acanthoma 207 // Tumour of the follicular infundibulum 208 // Melanocytic matricoma 209 // Spindle cell-predominant trichodiscoma 210 // Tumours with sebaceous differentiation 211 // Sebaceous carcinoma 211 // Sebaceous adenoma 213 // Sebaceoma 214 // Site-specific tumours 216 // Mammary Paget disease 216 // Extramammary Paget disease 217 // Adenocarcinoma of anogenital mammary-like glands 219 // Hidradenoma papilliferum 220 // Fibroadenoma and phyllodes tumour of anogenital // mammary-like glands 221 // 4 Tumours of haematopoietic and lymphoid origin 223 // Introduction 224 // Mycosis fungoides 226 // Variants of mycosis fungoides 231 // Folliculotropic mycosis fungoides 231 // Granulomatous slack skin 232 // Pagetoid reticulosis 233 // Sézary syndrome 234 // Primary cutaneous CD30+ T-cell // lymphoproliferative disorders 236 // Lymphomatoid papulosis 236 // Primary cutaneous anaplastic large cell lymphoma
238 // Cutaneous adult T-cell leukaemia/lymphoma 240 // Subcutaneous panniculitis-like T-cell lymphoma 242 // Cutaneous manifestations of chronic active EBV infection 244 Extranodal NK/T-cell lymphoma, nasal type 246 // Primary cutaneous peripheral T-cell lymphomas, // rare subtypes 248 // Primary cutaneous gamma-delta T-cell lymphoma 248 // Primary cutaneous CD8+ aggressive epidermotropic // cytotoxic T-cell lymphoma 249 // Primary cutaneous acral CD8+ T-cell lymphoma 250 // Primary cutaneous CD4+ small/medium T-cell // lymphoproliferative disorder 252 // Secondary cutaneous involvement in T-cell lymphomas // and leukaemias 254 // Systemic anaplastic large cell lymphoma 254 // Angioimmunoblastic T-cell lymphoma 254 // T-cell prolymphocytic leukaemia 255 // Primary cutaneous marginal zone (MALT) lymphoma 256 // Primary cutaneous follicle centre lymphoma 258 // Primary cutaneous diffuse large ?-cell lymphoma, leg type 260 Intravascular large ?-cell lymphoma 262 // EBV-positive mucocutaneous ulcer 263 // Lymphomatoid granulomatosis 265 // Cutaneous involvement in primarily extracutaneous // ?-cell lymphomas and leukaemias 266 // Mantle cell lymphoma 266 // Burkitt lymphoma 267 // Chronic lymphocytic leukaemia/ // small lymphocytic lymphoma 268 // T-lymphoblastic and B-lymphoblastic leukaemia/lymphoma 270 Elastic plasmacytoid dendritic cell neoplasm 271 // Cutaneous involvement in myeloid leukaemia 273 // Cutaneous mastocytosis 275 // Introduction to histiocytic and dendritic cell
neoplasms 279 // Langerhans cell histiocytosis 281 // Indeterminate cell histiocytosis/indeterminate dendritic // cell tumour 283 // Rosai-Dorfman disease 284 // Juvenile xanthogranuloma 285 // Erdheim-Chester disease 287 // Reticulohistiocytosis 289 // 5 Sort tissue tumours 291 // rrccjction 292 // Aioocytic tumours 294 // Atypical lipomatous tumour 294 // P omorphic liposarcoma 295 // _poma 296 // Sc ndle cell/pleomorphic lipoma 298 // ??? 300 // \\aevus lipomatosus superficialis 301 // r c - :c astio, myofibroblastic, and fibrohistiocytic tumours 302 V inflammatory fibroblastic sarcoma 302 // Demiatofibrosarcoma protuberans and variants 304 // -’exiform fibrohistiocytic tumour 307 // Superficial fibromatosis 308 // Dermatofibroma (fibrous histiocytoma) and variants 310 // Eoithelioid fibrous histiocytoma 313 // Rbromas 314 // Fibroma of tendon sheath 314 // Calcifying aponeurotic fibroma 314 // Sclerotic fibroma 315 // Nuchal-type fibroma 315 // Gardner fibroma 316 // Pleomorphic fibroma 316 // Elastofibroma 317 // Collagenous fibroma 317 // Superficial acral fibromyxoma 318 // Cutaneous myxoma 319 // Dermatomyofibroma 321 // Myofibroma and myofibromatosis 322 // Plaque-like CD34+ dermal fibroma 324 // Nodular fasciitis 326 // Smooth muscle tumours 328 // Cutaneous leiomyomas and variants 328 // Cutaneous leiomyosarcoma (atypical smooth // muscle tumour) 330 // Myojpericytic tumours 331 // Glomus tumour and variants 331 // Myopericytoma and variants 333 // Angioleiomyoma 334
// . ascular tumours 335 // Cutaneous angiosarcoma 335 // Haemangioendotheliomas 337 // Composite haemangioendothelioma 337 // Kaposiform haemangioendothelioma 337 // Pseudomyogenic haemangioendothelioma 338 // Retiform haemangioendothelioma 339 // Epithelioid haemangioendothelioma 339 // Kaposi sarcoma 341 // Atypical vascular lesion 344 // Cutaneous epithelioid angiomatous nodule 345 // Haemangiomas 346 // Cherry haemangioma 346 // Sinusoidal haemangioma 346 // Microvenular haemangioma 347 // Hobnail haemangioma 347 // Glomeruloid haemangioma 348 // Spindle cell haemangioma 349 // Epithelioid haemangioma 349 // Tufted haemangioma 350 // Angiokeratoma 351 // Infantile haemangioma 351 // Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma 352 // Lobular capillary haemangioma 353 // Verrucous venous malformation 354 // Arteriovenous malformation 355 // Lymphangioma (superficial lymphatic malformation) 356 // Neural tumours 358 // Neurofibroma and variants 358 // Solitary circumscribed neuroma 360 // Dermal nerve sheath myxoma 361 // Perineurioma 362 // Granular cell tumour 364 // Schwannoma 365 // Malignant peripheral nerve sheath tumour 367 // Tumours of uncertain differentiation 368 // Atypical fibroxanthoma and variants 368 // Pleomorphic dermal sarcoma 370 // Myxofibrosarcoma 371 // Epithelioid sarcoma 373 // Dermal clear cell sarcoma 374 // Ewing sarcoma 375 // Primitive non-neural granular cell tumour
376 // Cellular neurothekeoma 377 // 6 Inherited tumour syndromes associated with // skin malignancies 379 // Introduction 380 // Familial melanoma 383 // Xeroderma pigmentosum 386 // Naevoid basal cell carcinoma syndrome (Gorlin syndrome) 388 Carney complex 391 // BAP1 tumour predisposition syndrome 393 // Muir-Torre syndrome 395 // Contributors 398 // Declaration of interests 409 // IARC/WHO Committee for ICD-0 410 // Sources of figures and tables 411 // References 415 // Subject index 462 // List of abbreviations 470

Zvolte formát: Standardní formát Katalogizační záznam Zkrácený záznam S textovými návěštími S kódy polí MARC